ribavirin has been researched along with Cognition Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hopwood, M | 1 |
| Bajaj, JS; Forton, DM | 1 |
| Mingote-Adán, C; Solís-Herruzo, JA; Solis-Muñoz, P | 1 |
| Kraus, MR; Schäfer, A; Scheurlen, M | 1 |
| Bassiony, MM; El-Shabrawi, A; El-Shafeey, M; Fouad, E; Raya, Y; Yousef, A | 1 |
| Afdhal, NH; Alsop, D; Byrnes, V; Hill, E; Lenkinski, R; Lowry, D; Miller, A; Weinstein, C | 1 |
| Keicher, C; Kraus, MR; Porst, H; Schäfer, A; Scheurlen, M; Sprinzl, K; Teuber, G; Wollschläger, S | 1 |
| Kraus, MR; Reimer, P; Schäfer, A; Scheurlen, M; Wissmann, S | 1 |
| Dieterich, DT; Gorman, JM; Reichenberg, A | 1 |
| Longo, DL; Manns, MP; McHutchison, JG | 1 |
| Back-Madruga, C; Bieliauskas, LA; Fontana, RJ; Kronfol, Z; Lindsay, KL; Lok, AS; Padmanabhan, L; Snow, KK; Wright, EC | 1 |
| Brew, BJ; Dore, GJ; Kaldor, JM; Koorey, DJ; Krahn, MD; Maruff, P; Thein, HH | 1 |
| Saunders, JC | 1 |
2 review(s) available for ribavirin and Cognition Disorders
| Article | Year |
|---|---|
Definition and management of anemia in patients infected with hepatitis C virus.
Topics: Anemia; Antiviral Agents; Cardiovascular System; Cognition Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemoglobins; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2006 |
Neuropsychiatric symptoms of hepatitis C.
Topics: Antiviral Agents; Anxiety Disorders; Brain; Chronic Disease; Cognition Disorders; Depressive Disorder, Major; Hepatitis C; Humans; Neuropsychological Tests; Ribavirin | 2008 |
3 trial(s) available for ribavirin and Cognition Disorders
| Article | Year |
|---|---|
Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
Topics: Adult; Aged; Antiviral Agents; Aspartic Acid; Basal Ganglia; Choline; Cognition; Cognition Disorders; Creatine; Frontal Lobe; Hepatitis C, Chronic; Humans; Inositol; Interferons; Magnetic Resonance Spectroscopy; Middle Aged; Neuropsychological Tests; Polyethylene Glycols; Prospective Studies; Ribavirin; Surveys and Questionnaires | 2012 |
Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
Topics: Adult; Aged; Antiviral Agents; Cognition Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin | 2005 |
Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
Topics: Adult; Affect; Antiviral Agents; Cognition; Cognition Disorders; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
8 other study(ies) available for ribavirin and Cognition Disorders
| Article | Year |
|---|---|
Perspectives of a self-selected sample of former patients on the long-term health outcomes of interferon-based hepatitis C treatments: an exploratory study.
Topics: Adult; Aftercare; Anorexia; Antiviral Agents; Attitude of Health Personnel; Chronic Disease; Cognition Disorders; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neurotoxicity Syndromes; New South Wales; Patient Education as Topic; Qualitative Research; Quality of Life; Recurrence; Ribavirin; Sarcoidosis; Self Report; Severity of Illness Index; Treatment Outcome; Victoria | 2013 |
Cognitive improvement after HCV eradication: Extending the benefits.
Topics: Antiviral Agents; Cognition Disorders; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2013 |
Neurocognitive function and dysfunction after hepatitis C therapy.
Topics: Antiviral Agents; Cognition Disorders; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2014 |
Reply: To PMID 23300053.
Topics: Antiviral Agents; Cognition Disorders; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Ribavirin | 2014 |
Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt.
Topics: Adolescent; Adult; Antiviral Agents; Anxiety Disorders; Case-Control Studies; Cognition Disorders; Depressive Disorder; Egypt; Female; Hepatitis C; Humans; Interferons; Male; Middle Aged; Prevalence; Prospective Studies; Ribavirin; Risk Factors; Surveys and Questionnaires; Young Adult | 2015 |
Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C.
Topics: Adult; Antiviral Agents; Attention; Cognition; Cognition Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Psychological Tests; Psychometrics; Recombinant Proteins; Reproducibility of Results; Ribavirin; Treatment Outcome | 2013 |
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Cognition Disorders; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Memory; Middle Aged; Prospective Studies; Psychomotor Disorders; Psychomotor Performance; Reaction Time; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2005 |
Improved cognitive function as a consequence of hepatitis C virus treatment.
Topics: Adult; Antiviral Agents; Cognition Disorders; Cognitive Behavioral Therapy; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Neuropsychological Tests; Predictive Value of Tests; Prospective Studies; Quality of Life; Ribavirin; Treatment Outcome | 2007 |